Documents A to Z

ALL | | 1 | 2 | 3 | 4 | 5 | 7 | 8 | 9 | A | B | C | D | E | F | G | H | I | J | L | M | N | O | P | Q | R | S | T | U | V | W | Z

Notes on the Design of Bioequivalence Study: Emtricitabine/Tenofovir disoproxil fumarate (20 February 2024) PDF

Guideline/guidance

Notes on the Design of Bioequivalence Study: etravirine (6 February 2024) PDF

Guideline/guidance

Notes on the Design of Bioequivalence Study: Fluconazole (6 May 2025) PDF

Guideline/guidance

Notes on the Design of Bioequivalence Study: Gatifloxacin (18 February 2024) PDF

Guideline/guidance

Notes on the Design of Bioequivalence Study: Lamivudine/Tenofovir Alafenamide PDF

Notes on the Design of Bioequivalence Study: Lamivudine/Tenofovir Alafenamide/Dolutegravir PDF

Notes on the Design of Bioequivalence Study: Lamivudine/Tenofovir Disoproxil Fumarate PDF

Notes on the Design of Bioequivalence Study: Lamivudine/Tenofovir disoproxil fumarate (18 February 2024) PDF

Guideline/guidance

Notes on the Design of Bioequivalence Study: protionamide PDF

Guideline/guidance

Notes on the Design of Bioequivalence Study: Sulfamethoxazole/Trimethoprim/Isoniazid/Pyridoxine PDF

Guideline/guidance

Notes on the Design of Bioequivalence Study: valganciclovir PDF

Guideline/guidance

Notes on the design of bioequivalence study: Abacavir PDF

Guideline/guidance

Notes on the design of bioequivalence study: abacavir/dolutegravir/lamivudine PDF

Guideline/guidance

Notes on the design of bioequivalence study: Abacavir/Lamivudine PDF

Guideline/guidance

Notes on the design of bioequivalence study: abacavir/lamivudine/lopinavir/ritonavir PDF

Guideline/guidance

Notes on the design of bioequivalence study: albendazole PDF

Guideline/guidance

Notes on the design of bioequivalence study: amodiaquine PDF

Guideline/guidance

Notes on the design of bioequivalence study: amodiaquine/artesunate PDF

Guideline/guidance

Notes on the design of bioequivalence study: amoxicillin PDF

Guideline/guidance

Notes on the design of bioequivalence study: Amphotericin B (liposomal) PDF

Guideline/guidance

Notes on the design of bioequivalence study: arpraziquantel PDF

Guideline/guidance

Notes on the design of bioequivalence study: artemether + lumefantrine PDF

Guideline/guidance

Notes on the design of bioequivalence study: artemether/lumefantrine PDF

Guideline/guidance

Notes on the design of bioequivalence study: artesunate (rectal) PDF

Guideline/guidance

Notes on the design of bioequivalence study: artesunate/mefloquine PDF

Guideline/guidance

Notes on the design of bioequivalence study: artesunate/pyronaridine PDF

Guideline/guidance

Notes on the design of bioequivalence study: atazanavir/ritonavir PDF

Guideline/guidance

Notes on the design of bioequivalence study: azithromycin PDF

Guideline/guidance

Notes on the design of bioequivalence study: baloxavir marboxil PDF

Guideline/guidance

Notes on the design of bioequivalence study: baricitinib PDF

Guideline/guidance

Notes on the design of bioequivalence study: bedaquiline PDF

Guideline/guidance

Notes on the design of bioequivalence study: benzathine benzylpenicillin PDF

Guideline/guidance

Notes on the design of bioequivalence study: cabotegravir PDF

Guideline/guidance

Notes on the design of bioequivalence study: cabotegravir + rilpivirine PDF

Guideline/guidance

Notes on the design of bioequivalence study: clofazimine PDF

Guideline/guidance

Notes on the design of bioequivalence study: cycloserine PDF

Guideline/guidance

Notes on the design of bioequivalence study: daclatasvir PDF

Notes on the design of bioequivalence study: darunavir PDF

Guideline/guidance

Notes on the design of bioequivalence study: darunavir + ritonavir PDF

Guideline/guidance

Notes on the design of bioequivalence study: delamanid PDF

Guideline/guidance

Notes on the design of bioequivalence study: desogestrel PDF

Guideline/guidance

Notes on the design of bioequivalence study: dexamethasone PDF

Guideline/guidance

Notes on the design of bioequivalence study: diethylcarbamazine PDF

Guideline/guidance

Notes on the design of bioequivalence study: dihydroartemisinin + piperaquine tetraphosphate PDF

Guideline/guidance

Notes on the design of bioequivalence study: dolutegravir PDF

Guideline/guidance

Notes on the design of bioequivalence study: efavirenz PDF

Guideline/guidance

Notes on the Design of Bioequivalence Study: Emtricitabine/Tenofovir Alafenamide PDF

Notes on the Design of Bioequivalence Study: Emtricitabine/Tenofovir Alafenamide/Dolutegravir PDF

Guideline/guidance

Notes on the design of bioequivalence study: Emtricitabine/Tenofovir Alafenamide/Efavirenz PDF

Notes on the Design of Bioequivalence Study: Emtricitabine/Tenofovir Disoproxil Fumarate /Dolutegravir PDF